Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...

Novo Nordisk announced its CagriSema GLP-1 weight loss drug underperformed Eli Lilly's tirzepatide in a trial. Separately, Lilly announced patients can use a single injector to hold a month's supply ...

From the very beginning, self-professed “Stage Girl” Eli knew she wanted to make an album about a starry-eyed girl journeying through a singing competition. “Growing up, a lot of my dreams and ...

It’s a good day to be the pharmaceutical giant Eli Lilly. Right now, Eli Lilly appears to be the leader in the GLP-1 race amid multiple difficult headwinds for Novo Nordisk. As of this writing, Novo ...

CSL granted Eli Lilly certain rights for clazakizumab CSl to receive upfront payment of $100 million CSL shares up 2.1% CSL will retain exclusive rights to develop and commercialise clazakizumab for ...

Eli Manning was among the Super Bowl MVPs who were acknowledged prior to Super Bowl LX. But unlike the others in attendance, the former New York Giants quarterback was the only eligible one who is not ...

Eli Lilly has been busy building its drug pipeline for the future. The company currently sells the world's best-selling drug. It just bought Orna Therapeutics, an innovative drugmaker. Investing in ...

FanGraphs released their top 100 prospects for the 2026 season, and Washington Nationals 2025 first overall pick Eli Willits came in at No. 15. What got him drafted in that coveted spot was his ...

In the lucrative obesity drug race, there is Eli Lilly — and then there's everybody else. A pair of headlines Monday reinforced Lilly's dominance: Its lone commercial rival, Novo Nordisk , released ...

Robert Turbin, a fourth-round draft pick in 2012, played for eight years in the NFL. Illustration: Dan Goldfarb / The Athletic; Otto Greule Jr / Getty Images The Athletic has live coverage of the 2026 ...

Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi ...

Notre Dame tight end Eli Raridon is among the more underrated prospects at his position in the 2026 NFL Draft. Raridon enjoyed a breakout season in 2025 by recording 32 catches for 482 yards, ...